EP2957570 - POLYCLONAL ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE AND USES THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 21.02.2020 Database last updated on 16.07.2024 | |
Former | The patent has been granted Status updated on 15.03.2019 | ||
Former | Grant of patent is intended Status updated on 05.11.2018 | ||
Former | Examination is in progress Status updated on 07.04.2017 | Most recent event Tooltip | 01.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 03.08.2022 [2022/31] | Applicant(s) | For all designated states Immunimed Inc. 6-62 Scurfield Boulevard Winnipeg, Manitoba R3Y 1M5 / CA | [2019/16] |
Former [2015/52] | For all designated states Immunimed Inc. 6-62 Scurfield Boulevard Winnipeg, Manitoba R3Z 1M5 / CA | Inventor(s) | 01 /
Maiti, Pradip K. 6-62 Scurfield Blvd. Winnipeg, Manitoba R3Y 1M5 / CA | [2015/52] | Representative(s) | Franke, Dirk Franke & Partner Patent- und Rechtsanwälte Widenmayerstraße 25 80538 München / DE | [2015/52] | Application number, filing date | 15173034.8 | 19.06.2015 | [2015/52] | Priority number, date | US201462015339P | 20.06.2014 Original published format: US 201462015339 P | [2015/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2957570 | Date: | 23.12.2015 | Language: | EN | [2015/52] | Type: | B1 Patent specification | No.: | EP2957570 | Date: | 17.04.2019 | Language: | EN | [2019/16] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 23.10.2015 | Classification | IPC: | C07K16/02, C07K16/12, A61K39/00, A61K39/08 | [2015/52] | CPC: |
C07K16/1282 (EP,US);
C07K16/02 (US);
A61K39/08 (EP,US);
A61K39/39591 (EP,US);
A61P31/04 (EP);
A61K2039/505 (EP,US);
A61K2039/507 (US);
C07K2317/11 (EP,US);
C07K2317/23 (EP,US);
C07K2317/76 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/31] |
Former [2015/52] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | POLYKLONALE ANTIKÖRPER GEGEN CLOSTRIDIUM DIFFICILE UND IHRE VERWENDUNG | [2015/52] | English: | POLYCLONAL ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE AND USES THEREOF | [2015/52] | French: | ANTICORPS POLYCLONAUX CONTRE LES TOXINES DE CLOSTRIDIUM DIFFICILE ET UTILISATIONS ASSOCIEES | [2015/52] | Examination procedure | 23.06.2016 | Amendment by applicant (claims and/or description) | 23.06.2016 | Examination requested [2016/31] | 06.04.2017 | Despatch of a communication from the examining division (Time limit: M04) | 08.08.2017 | Reply to a communication from the examining division | 16.10.2018 | Cancellation of oral proceeding that was planned for 17.10.2018 | 17.10.2018 | Date of oral proceedings (cancelled) | 06.11.2018 | Communication of intention to grant the patent | 05.03.2019 | Receipt of the translation of the claim(s) | 08.03.2019 | Fee for grant paid | 08.03.2019 | Fee for publishing/printing paid | Opposition(s) | 20.01.2020 | No opposition filed within time limit [2020/13] | Fees paid | Renewal fee | 29.06.2017 | Renewal fee patent year 03 | 27.06.2018 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 19.06.2015 | AL | 17.04.2019 | AT | 17.04.2019 | CY | 17.04.2019 | CZ | 17.04.2019 | DK | 17.04.2019 | EE | 17.04.2019 | ES | 17.04.2019 | FI | 17.04.2019 | HR | 17.04.2019 | IT | 17.04.2019 | LT | 17.04.2019 | LV | 17.04.2019 | MC | 17.04.2019 | MK | 17.04.2019 | MT | 17.04.2019 | NL | 17.04.2019 | PL | 17.04.2019 | RO | 17.04.2019 | RS | 17.04.2019 | SE | 17.04.2019 | SI | 17.04.2019 | SK | 17.04.2019 | SM | 17.04.2019 | TR | 17.04.2019 | IE | 19.06.2019 | LU | 19.06.2019 | BE | 30.06.2019 | CH | 30.06.2019 | LI | 30.06.2019 | BG | 17.07.2019 | NO | 17.07.2019 | GR | 18.07.2019 | IS | 17.08.2019 | PT | 17.08.2019 | [2022/31] |
Former [2021/34] | HU | 19.06.2015 | |
AL | 17.04.2019 | ||
AT | 17.04.2019 | ||
CY | 17.04.2019 | ||
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
EE | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
IT | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
MC | 17.04.2019 | ||
MT | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RO | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
SI | 17.04.2019 | ||
SK | 17.04.2019 | ||
SM | 17.04.2019 | ||
TR | 17.04.2019 | ||
IE | 19.06.2019 | ||
LU | 19.06.2019 | ||
BE | 30.06.2019 | ||
CH | 30.06.2019 | ||
LI | 30.06.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2021/33] | HU | 19.06.2015 | |
AL | 17.04.2019 | ||
AT | 17.04.2019 | ||
CY | 17.04.2019 | ||
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
EE | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
IT | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
MC | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RO | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
SI | 17.04.2019 | ||
SK | 17.04.2019 | ||
SM | 17.04.2019 | ||
TR | 17.04.2019 | ||
IE | 19.06.2019 | ||
LU | 19.06.2019 | ||
BE | 30.06.2019 | ||
CH | 30.06.2019 | ||
LI | 30.06.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2021/26] | AL | 17.04.2019 | |
AT | 17.04.2019 | ||
CY | 17.04.2019 | ||
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
EE | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
IT | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
MC | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RO | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
SI | 17.04.2019 | ||
SK | 17.04.2019 | ||
SM | 17.04.2019 | ||
TR | 17.04.2019 | ||
IE | 19.06.2019 | ||
LU | 19.06.2019 | ||
BE | 30.06.2019 | ||
CH | 30.06.2019 | ||
LI | 30.06.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2020/25] | AL | 17.04.2019 | |
AT | 17.04.2019 | ||
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
EE | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
IT | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
MC | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RO | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
SI | 17.04.2019 | ||
SK | 17.04.2019 | ||
SM | 17.04.2019 | ||
TR | 17.04.2019 | ||
IE | 19.06.2019 | ||
LU | 19.06.2019 | ||
BE | 30.06.2019 | ||
CH | 30.06.2019 | ||
LI | 30.06.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2020/21] | AL | 17.04.2019 | |
AT | 17.04.2019 | ||
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
EE | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
IT | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
MC | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RO | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
SK | 17.04.2019 | ||
SM | 17.04.2019 | ||
TR | 17.04.2019 | ||
IE | 19.06.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2020/17] | AL | 17.04.2019 | |
AT | 17.04.2019 | ||
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
EE | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
IT | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
MC | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RO | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
SK | 17.04.2019 | ||
SM | 17.04.2019 | ||
TR | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2020/14] | AL | 17.04.2019 | |
AT | 17.04.2019 | ||
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
EE | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
IT | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
MC | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RO | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
SK | 17.04.2019 | ||
SM | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2020/12] | AL | 17.04.2019 | |
AT | 17.04.2019 | ||
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
EE | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
IT | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
MC | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RO | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
SK | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2020/11] | AL | 17.04.2019 | |
AT | 17.04.2019 | ||
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
EE | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
MC | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RO | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
SK | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2020/10] | AL | 17.04.2019 | |
AT | 17.04.2019 | ||
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
MC | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RO | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2020/09] | AL | 17.04.2019 | |
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
MC | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2020/08] | AL | 17.04.2019 | |
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
MC | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2020/04] | AL | 17.04.2019 | |
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2019/52] | AL | 17.04.2019 | |
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
PT | 17.08.2019 | ||
Former [2019/51] | AL | 17.04.2019 | |
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
NL | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
PT | 17.08.2019 | ||
Former [2019/50] | AL | 17.04.2019 | |
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
NL | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
PT | 17.08.2019 | ||
Former [2019/49] | AL | 17.04.2019 | |
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
NL | 17.04.2019 | ||
SE | 17.04.2019 | ||
NO | 17.07.2019 | ||
PT | 17.08.2019 | ||
Former [2019/48] | ES | 17.04.2019 | |
FI | 17.04.2019 | ||
LT | 17.04.2019 | ||
NL | 17.04.2019 | ||
SE | 17.04.2019 | ||
NO | 17.07.2019 | ||
PT | 17.08.2019 | ||
Former [2019/47] | ES | 17.04.2019 | |
FI | 17.04.2019 | ||
LT | 17.04.2019 | ||
NL | 17.04.2019 | ||
NO | 17.07.2019 | ||
Former [2019/44] | NL | 17.04.2019 | Documents cited: | Search | [I]WO9413264 (OPHIDIAN PHARM INC [US], et al) [I] 1-10 * the whole document * * see in particular abstract; examples 8-10; table 13, 14, 15 *; | [X]WO9902188 (UNIV ARIZONA [US]) [X] 1-10 * the whole document * * see in particular abstract; page 7; Examples 1, 3, 4, 8, 9 *; | [AD]CA2560283 (NUTRATECH INC [CA]) [AD] 1-10 * the whole document *; | [A]US2007071795 (PRADIP MAITI [CA], et al) [A] 1-10 * the whole document *; | [T]WO2014169344 (IMMURON LTD [AU]) [T] 1-10 * the whole document ** see in particular abstract; examples 1-23*; | [I] - KINK J A ET AL, "ANTIBODIES TO RECOMBINANT CLOSTRIDIUM DIFFICILE TOXINS A AND B ARE EFFECTIVE TREATMENT AND PREVENT RELAPSE OF C. DIFFICILE-ASSOCIATED DISEASE IN A HAMSTER MODEL OF INFECTION", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, (19980501), vol. 66, no. 5, ISSN 0019-9567, pages 2018 - 2025, XP002912254 [I] 1-10 * the whole document * * see in particular abstract; pages 2019, 2024; tables 1 and 2; figures 5, 6 * | [A] - MIN S SONG ET AL, "Growth inhibition of Clostridium perfringens vegetative cells and spores using chicken immunoglobulin Y.", JOURNAL OF FOOD SAFETY 2009 CORRESPONDENCE ADDRESS, HOON H. SUNWOO, CJ FOODS R&D, CJ CORPORATION 636, GURO-DONG, GURO-GU, SEOUL, SOUTH KOREA. TEL. 1-780-492-0547. FAX 1-780-669-7181. E-MAIL [email protected], (20090101), vol. 29, no. 4, pages 511 - 520, XP009186700 [A] 1-10 * the whole document * * see in particular abstract; * DOI: http://dx.doi.org/10.1111/j.1745-4565.2009.00173.x | Examination | WO2012092469 | by applicant | CA2560283 | CA2629790 | US7713527 | US7820171 | US8257709 | US8921529 | US8986697 | - KATCHAR, K. ET AL., "Association between IgG2 and IgG3 subclass responses to toxin a and recurrent Clostridium difficile-assocaited disease", CLIN. GASTROENTEROL. HEPATOL., (2007), vol. 5, doi:doi:10.1016/j.cgh.2007.02.025, pages 707 - 713, XP022096355 DOI: http://dx.doi.org/10.1016/j.cgh.2007.02.025 | - KELLY, C.P.; KYNE, L., "The host immune response to Clostridium difficile", J. MED. MICROBIAL., (2011), vol. 60, doi:doi:10.1099/jmm.0.030015-0, pages 1070 - 1079, XP055070512 DOI: http://dx.doi.org/10.1099/jmm.0.030015-0 | - FU ET AL., WORLD J. GASTROENTEROL, (2004), vol. 10, pages 2756 - 2758 | - PHARMACOPEIAL CONVENTION COUNCIL OF EXPRESS, (2004), vol. 22, no. 27, page 2728 | - PARESDES-SABJA, D; SARKER, M.R., J MED. MICROBIAL., (2012), vol. 61, page 1208 | - MILLER B.A. ET AL., INFECT CONTROL HOSP EPIDEMIOL., (2011), vol. 32, page 387 | - BOUZA, E., CLIN. MICROBIAL INFECT., (2012), vol. 18, no. 5 | - KHANNA, S.; D.S. MAYO, CLIN PROC., (2012), vol. 87, page 1106 | - JOHNSON, S. ET AL., ANTIMICROBIAL AGENTS & CHEMOTHERAPY, (2012), vol. 56, page 4043 | - ANANTHAKRISHNAN A.N., GASTROENTEROL HEPATOL., (2011), vol. 8, page 17 | - SANCHEZ-K. ET AL., J. MED. MICROBIAL., (2008), vol. 57, page 717 | - LOWY, . ET AL., N ENGL. J MED., (2010), vol. 362, page 197 | - BASSERI, R.J. ET AL., GASTROENTEROL. HEPATOL., (2011), vol. 7, page 455 | - HULISZ, D. J., MANAG CARE PHARM, (2004), vol. 10, page 299 | - FURNARI, M. ET AL., J GASTROINTESTIN LIVER DIS., (2012), vol. 21, page 157 |